Mccormick Frank insider trades
Mccormick Frank has filed 13 Form 4s with the SEC that we hold, for BridgeBio Pharma, Inc. (BBIO) (Director) and BridgeBio Oncology Therapeutics, Inc. (BBOT) (Director). Across all of them we count 0 purchases worth $0 and 9 sales worth $25.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($13.3M). The largest single trade was a sale of 111,755 shares of BridgeBio Pharma, Inc. worth $7.3M, dated 2025-10-29. The first filing on our record is dated 2023-02-23 and the latest 2026-06-24.
BridgeBio Pharma, Inc. (BBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-12-26 | S, sale reported on Form 4 | 100,000 | $4.2M | 2023-12-28 |
| 2025-06-24 | S, sale reported on Form 4 | 100,000 | $4.4M | 2025-06-26 |
| 2025-09-05 | S, sale reported on Form 4 | 74,000 | $3.9M | 2025-09-08 |
| 2025-10-27 | S, sale reported on Form 4 | 1,641 | $106.7K | 2025-10-29 |
| 2025-10-29 | S, sale reported on Form 4 | 111,755 | $7.3M | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 31,116 | $2.1M | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 43,393 | $3.0M | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 8,598 | $589.0K | 2025-10-31 |
| 2025-10-29 | S, sale reported on Form 4 | 3,497 | $236.1K | 2025-10-31 |
BridgeBio Oncology Therapeutics, Inc. (BBOT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1257809) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms